• Biotech adds CRISPR Technology for Models Development

News & Views

Biotech adds CRISPR Technology for Models Development

Apr 25 2021

Setsuro Tech, a Japanese biotechnology start-up using genome-editing techniques to develop and supply cell and animal models, has signed a non-exclusive license for access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan.

“The versatility and programmability of Cas9 has enabled the CRISPR/Cas9 technology to become a revolutionary approach in biological research,” said Eric Rhodes, CEO of Dublin-based ERS Genomics. “We are pleased to support Setsuro Tech with this license agreement so that they are able to continue providing supportive tools and services for research activities.”

“Our technology enables us to provide researchers with genome-edited models quickly and at relatively low cost,” commented Shinichiro Takezawa, CEO, Setsuro Tech, Tokushima. “The license from ERS expands our portfolio and having access to advanced technologies such as CRISPR/Cas9 will allow us to continue our high-quality offerings that combine CRISPR/Cas9 with our patent-pending technologies.”

Financial details of the agreement were not disclosed.

Further information online

Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions


ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia


Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA


Aug 25 2024 Copenhagen, Denmark

View all events